Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Sunday, August 31, 2025.
GT Biopharma, Inc. (NASDAQ:GTBP)
Long-Term Downtrend (-90) - GTBP is in a strong downtrend that is likely to continue. While GTBP is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid GTBP?
MarketClub looks at technical strength and momentum to determine if the timing is right for GTBP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for GTBP
The long-term trend has been DOWN since Jul 7th, 2025 at 2.1006
The intermediate-term trend has been DOWN since Jul 3rd, 2025 at 2.7500
The short-term trend has been DOWN since Aug 28th, 2025 at 1.0800
Smart Scan Analysis for GTBP
Based on our trend formula, GTBP is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 0.960000 | 0.967500 | 0.910064 | 0.935000 | -0.032400 |
| Prev. Close | Volume | Bid | Ask | Time |
| 0.934500 | 99478 | 2025-08-29 15:59:39 |
| Year High | 5.85 | Year High Date | 2018-01-10 |
| Year Low | 0.61 | Year Low Date | 2018-11-14 |
| 52wk High | 4.1 | 52wk High Date | 2024-12-23 |
| 52wk Low | 0.96 | 52wk Low Date | 2025-08-28 |
| Average Volume | 111,097 | Shares Outstanding | 3,558 |
| Assets | 7,124,000M | Liabilities | 2,307,000M |
| P/E Ratio | -0.54110000 | Volatility | 218 |